^
+ Follow DR. DONALD EASTON Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 347113
                    [Title] => Benefits of clopidogrel in patients with cardiovascular disease reaffirmed
                    [Summary] => Taking the anti-clotting medicine clopidogrel together with aspirin is beneficial to patients with known cardiovascular disease or those who suffered a heart attack or stroke, but not in patients who only have risk factors for developing a cardiovascular disease, according to the results of an international study called CHARISMA. 

[DatePublished] => 2006-07-13 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 256781 [Title] => Neurologists hail results of new study [Summary] => A well-respected neurologist and medical researcher from Hong Kong recently presented the results of the MATCH trial, the largest study conducted to date in a high-risk population of cerebrovascular patients.

In a symposium at the Philippine Neurological Association’s 10th mid-year convention held on Panglao Island in Bohol, Dr. Lawrence Wong discussed the trial results which he considers a breakthrough in the management of cerebrovascular diseases.

His presentation was entitled "Risk Stratification for Secondary Stroke Prevention."
[DatePublished] => 2004-07-08 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
DR. DONALD EASTON
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 347113
                    [Title] => Benefits of clopidogrel in patients with cardiovascular disease reaffirmed
                    [Summary] => Taking the anti-clotting medicine clopidogrel together with aspirin is beneficial to patients with known cardiovascular disease or those who suffered a heart attack or stroke, but not in patients who only have risk factors for developing a cardiovascular disease, according to the results of an international study called CHARISMA. 

[DatePublished] => 2006-07-13 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 256781 [Title] => Neurologists hail results of new study [Summary] => A well-respected neurologist and medical researcher from Hong Kong recently presented the results of the MATCH trial, the largest study conducted to date in a high-risk population of cerebrovascular patients.

In a symposium at the Philippine Neurological Association’s 10th mid-year convention held on Panglao Island in Bohol, Dr. Lawrence Wong discussed the trial results which he considers a breakthrough in the management of cerebrovascular diseases.

His presentation was entitled "Risk Stratification for Secondary Stroke Prevention."
[DatePublished] => 2004-07-08 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with